Contents:

CHOLESTEROL AND OTHER CARDIOVASCULAR TESTING A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-2 Product Definitions and Scope of Study I-3 Lipid Panel Test/Complete Lipid Profile I-3 Total Cholesterol Test I-3 HDL Cholesterol Test I-3 Apolipoprotein B I-3 Other Apolipoprotein Tests I-3 II. Executive Summary 1. Industry Overview II-1 Global Market Outlook II-1 No-Holds Barred Growth II-1 Tests Conducted Worldwide II-1 Analysis by Geographic Region II-1 Analysis by Product Segment II-2 Home/OTC Cholesterol Test Kits Market Set for Double-Digit Growth II-2 Growth Drivers II-2 Aging Population Drives Home Testing Market II-2 Extensive Awareness Campaigns for Common People II-2 Global In-Vitro Diagnostic Products Market: An Overview II-3 Growth Trends II-4 Table 1: World In-Vitro Diagnostic (IVD) Testing Market (2004): Percentage Breakdown by Value Sales for United States, Europe, Japan, Asia-Pacific, and Rest of World (includes corresponding Graph/Chart) II-4 Established Players Dominate a Fragmented Industry II-4 Table 2: Leading Players in the Global In-Vitro Diagnostics Market (*) (2006): Percentage Breakdown of Value Sales for Roche, Abbott, Siemens, Beckman Coulter, Dade Behring and Others II-5 Cardiac IVD Market to Grow II-5 2. An Insight into Cardiovascular Diseases II-6 The Heart of Heart Problems II-6 Types of Cardiovascular Diseases/Disorders II-6 Coronary Artery Disease II-6 Hyperlipidemia – An Important Risk Factor of Heart Disease II-6 Hypertension – The Silent Killer II-7 Two-Pronged Approach to Counter CVD II-8 Cardiovascular Risk Assessment II-8 3. Good & Bad of Cholesterol II-9 Blood Cholesterol – The Principal Cardiac Risk Marker II-9 Types of Cholesterol II-9 Total Cholesterol (TC) II-9 High Density Lipoprotein (HDL) II-9 Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein (VLDL) II-10 Triglycerides (TRG) II-10 Glucose (GLU) II-10 Alanine Aminotransferase (ALT) II-10 Outcomes of High Blood Cholesterol II-10 Atherosclerosis II-10 Coronary Heart Disease (CHD) II-10 Risk Factors and Risk Levels II-10 Risk Factors II-10 Risk Levels II-11 Risk Level Based on Total Cholesterol Concentration II-11 LDL-Cholesterol Risk Levels II-11 HDL-Cholesterol Risk Levels II-11 Triglyceride Risk Levels II-11 4. Cholesterol Testing & CVD Risk Assessment Techniques II-12 Cholesterol Testing II-12 Need for Cholesterol Testing II-12 Candidates for Cholesterol Testing II-12 Test Procedure II-13 Time of Testing – Crucial for Heart Disease Patients II-13 Types of Cholesterol Testing II-14 Lipid Panel Test/Lipid Profile II-14 Total Cholesterol Test II-14 HDL Cholesterol Test II-14 Apolipoprotein Tests II-15 Apolipoprotein A-1 Test II-15 Apolipoprotein B100 Test II-15 ApoE Genotyping Test II-15 Apolipoprotein CII II-16 Table 3: Prices of Cholesterol Tests by Type II-16 Other Cholesterol Markers II-16 LDL Cholesterol Testing II-16 LDL Cholesterol Test – The First Cholesterol Testing Method II-16 Triglycerides/VLDL Cholesterol Testing II-16 RLP Cholesterol II-17 Non Instrumented Technologies II-17 Heart Disease Diagnosis Tests II-17 Non-Invasive Tests II-17 Invasive Tests II-17 Other CVD Markers II-18 Creatine Kinase MB II-18 Troponin T and Troponin I II-18 Myoglobin II-19 P-selectin Profile II-19 C-reactive Protein II-19 Endothelial Dysfunction II-20 Homocysteine II-20 Plasminogen Activator Inhibitor-1 II-21 s-100 Protein II-21 Thrombus Precursor Protein II-21 Other Cardiac Markers II-21 5. Point-of-Care & Home Cholesterol Testing II-22 Point of Care (POC) Medical Diagnostics II-22 Table 4: Global Point of Care Diagnostics Market (2006): Percentage Breakdown of Value Sales by Segment – Hospital Labs, Commercial Labs, Self Testing and Point of Care II-22 POC Testing Market II-23 Table 5: Leading Players in the Worldwide POC Cardiac Testing Market (2004): Percentage Breakdown of Value Sales for Biosite, Dade Behring, Spectral Diagnostics, Roche, and Others (includes corresponding Graph/Chart) II-23 Development of Home Cholesterol Testing Kits II-23 Table 6: Cholesterol and Other Cardiovascular Test Kits Offered by Leading Companies II-23 6. Cholesterol Control & Treatment Modalities II-24 Prevention is Better than Cure II-24 Dietary Therapy II-24 Healthy Diet II-24 Exercises II-25 Drug Therapy II-25 Classification of Cholesterol Lowering Drugs II-25 Bile Acid Sequestrants II-25 Nicotinic Acid II-25 HMG CoA Reductase Inhibitors (Statins) II-26 Other Drugs (Fibric Acids and Probucol) II-26 Testing After Commencing Drug Therapy II-26 7. Product Innovations/Launches II-27 Home Access Health Launches CheckUp America Cholesterol Panel II-27 Cholestech Launches Lipid Profile*ALT Test Cassette II-27 Home Access Health Develops an Algorithm for Home Test II-27 Cholestech Unveils Innovative Dermatology Kit II-27 Beckman Coulter Unveils UniCel® DxI 600 Access® Immunoassay System II-28 Polymer Technology Systems to Launch Direct LDL Cholesterol Test II-28 Dade Behring Unveils CardioPhase(R) hsCRP Test II-29 PTS to Distribute First Ever Direct LDL Cholesterol Test II-29 Liposcience Reinstates Blood Cholesterol Test II-29 Akers Launches TrII-Cholesterol Test II-29 Dade Behring Unveils Homocysteine Test on BN(TM) Systems II-30 Axis-Shield Introduces BNP Assay for IMx® system of Abbott II-30 Roche Unveils Cardiac pro-BNP Test II-30 Accutech Introduces a new Diagnostic Test called CholesTrak for Women II-30 8. Recent Industry Activity II-31 TRICARE Includes Atherotech’s VAP® Test II- 31 PreMD Receives NSE Letter from US FDA for POC Skin Cholesterol Test II-31 Amic Gains License for Roche’s Cardiac Marker II-31 Acrongenomics and Molecular Vision Enter into Joint Collaboration Agreement II-32 diaDexus and Fisher HealthCare Sign Agreement II-32 Beckman Coulter Partners for Cardiovascular Research Project II-32 Siemens Acquires Bayer’s Diagnostic Division II-33 Response Biomedical Gains Approval to Sell RAMII® NT- proBNP Test II-33 Endothelix Obtains FDA Approval for VENDYS® Cardiovascular Test II-33 Cholestech Receives CLIA Waived Status for Lipid Profile ALT Test Panel II-33 Kellogg Partners with Omron Healthcare and BIOSAFE® II-34 Siemens Acquires Dade Behring II-34 Inverness Medical Innovations Concludes Cholestech Acquisition II-34 QuantRX Biomedical Increases Stake in FluoroPharma **Relevance II-35 Celera Takes Over Berkeley HeartLab II-35 Inverness Medical Innovations Completes Acquisition of HemoSense II-35 LipoScience and BioReference Announce Collaboration II-35 PreMD and AstraZeneca Sign Distribution Agreement II-36 Atherotech Reaches an Agreement with Source Scientific II-36 Siemens Acquires Diagnostic Products Corporation II-36 Nanogen Acquires Spectral’s Cardiac Test Division II-37 Instant Technologies Takes Over Accu-Stat Diagnostics II-37 Source Scientific and Atherotech Collaborate for VAP Test Devices II-37 Abbott Receives Non-exclusive Sublicense for Diagnostic Use of PIGF II-37 Cholestech to Supply LDX® System to Mexican Ministry of Communications & Tranportation II-38 PTS Enters into a Distribution Agreement with Medical Home Products II-38 Olympus’ AU3000i to Expand Market for Bayer’s BNP Assay II-38 PTS to Provide Test Strips to Lifestream Technologies for New Cholesterol/HDL Test II-38 Skylight Biotech to Start Cholesterol Testing Center for Animals II-38 FDA Grants CLIA Waiver for Biosite’s Triage(R) BNP Test II-39 Response Biomedical Wins Nonexclusive License Rights for NT- proBNP and Troponin T II-39 Medicure Gains Licensing Rights of Cholesterol- Lowering Technology II-39 Atherotech Collaborates with Resverlogix Corp II-39 IMI Enters into an Agreement with McNeil II-39 Nymox Pharmaceutical Receives Patent for Saliva Cholesterol Test II-40 LabCorp Ties Up with Atherotech to Offer VAP Cholesterol Test II-40 ABAXIS Bags FDA Approval for Three Assays II-40 Cholestech Obtains Approval to Market its Cholestech GDX™ System in Canada II-40 9. Focus on Select Global Players II-41 AccuTech, LLC (US) II-41 Axis-Shield Plc (UK) II-41 Beckman Coulter, Inc. (US) II-41 F. Hoffmann-La Roche Ltd (Switzerland) II-42 Home Access Health Corporation (US) II-42 Inverness Medical Innovations, Inc. (US) II-43 Biosite Inc. (US) II-43 Cholestech Corporation (US) II-44 Polymer Technology Systems, Inc. (USA) II-44 Siemens Healthcare Diagnostics, Inc. (USA) II-45 10. Global Market Perspective II-46 Table 7: World Recent Past, Current & Future Market Analysis for Cholesterol & Other Cardiovascular Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) II-46 Table 8: World Long-term Projections for Cholesterol & Other Cardiovascular Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) II-47 Table 9: World 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-48 Table 10: World Recent Past, Current & Future Market Analysis for Lipid Panel Test/Complete Lipid Profile Test by Geographic Region –United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) II-49 Table 11: World Long-term Projections for Lipid Panel Test/ Complete Lipid Profile Test by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) II-50 Table 12: World 10-Year Perspective for Lipid Panel Test/ Complete Lipid Profile Test by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-51 Table 13: World Recent Past, Current & Future Market Analysis for Total Cholesterol Testing by Geographic Region –United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) II-52 Table 14: World Long-term Projections for Total Cholesterol Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) II-53 Table 15: World 10-Year Perspective for Total Cholesterol Testing by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-54 Table 16: World Recent Past, Current & Future Market Analysis for HDL Cholesterol Testing by Geographic Region –United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) II-55 Table 17: World Long-term Projections for HDL Cholesterol Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) II-56 Table 18: World 10-Year Perspective for HDL Cholesterol Testing by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-57 Table 19: World Recent Past, Current & Future Market Analysis for Apolipoprotein B Tests by Geographic Region –United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) II-58 Table 20: World Long-term Projections for Apolipoprotein B Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) II-59 Table 21: World 10-Year Perspective for Apolipoprotein B Tests by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-60 Table 22: World Recent Past, Current & Future Market Analysis for Other Apolipoprotein Tests by Geographic Region –United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) II-61 Table 23: World Long-term Projections for Other Apolipoprotein Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) II-62 Table 24: World 10-Year Perspective for Other Apolipoprotein Tests by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-63 III. MARKET 1. The United States III-1 A.Market Analysis III-1 Market Outlook III-1 Cardiovascular Market: Startling Statistics III-1 Table 25: Prevalence of Cardiovascular Disease (CVD) in the US: Population by Disease Type (in 000s) (includes corresponding Graph/Chart) III-2 Cholesterol Testing – NCEP Recommendations Spurs Potential III-2 Trends and Issues III-3 Innovations Drive the Usage of Cardiovascular Monitoring Systems III-3 Sterols and Stanols: Cholesterol-lowering Products III-3 Cholesterol POCT Market: An Overview III-3 Increasing Cardiovascular Ailments Drive Sales of Home Test Devices III-4 Table 26: US Recent Past, Current & Future Analysis for Home Cholesterol Monitoring Kits: Annual Sales Figures in US$ Million for Years 2000 through 2010 III-4 Product Innovations/Launches III-5 Strategic Corporate Developments III-7 Key Players III-14 AccuTech, LLC III-14 Beckman Coulter, Inc. III-15 Home Access Health Corporation III-15 Inverness Medical Innovations, Inc. III-15 Biosite Inc.. III-16 Cholestech Corporation III-16 Polymer Technology Systems, Inc. III-17 Siemens Healthcare Diagnostics, Inc. III-17 B.Market Analytics III-18 Table 27: US Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-18 Table 28: US Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-19 Table 29: US 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-20 2. Canada III-21 A.Market Analysis III-21 Market Outlook III-21 Strategic Corporate Developments III-21 B.Market Analytics III-23 Table 30: Canadian Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test / Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-23 Table 31: Canadian Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includescorresponding Graph/Chart) III-24 Table 32: Canadian 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-25 3. Japan III-26 A.Market Analysis III-26 Market Outlook III-26 Home/OTC Cholesterol Testing Market III-26 Table 33: Japanese Recent Past, Current & Future Analysis for Home Cholesterol Monitoring Kits Market: Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-26 B.Market Analytics III-27 Table 34: Japanese Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-27 Table 35: Japanese Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-28 Table 36: Japanese 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-29 4. Europe III-30 A.Market Analysis III-30 Market Outlook III-30 Home Cholesterol Monitoring Kits in Western Europe III-30 Table 37: Western Europe Market for Home Cholesterol Monitoring Kits - Recent Past, Current & Future Analysis: Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-30 Strategic Corporate Developments III-30 B.Market Analytics III-31 Table 38: European Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Geographic Region – France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-31 Table 39: European Long-term Projections for Cholesterol & Other Cardiovascular Testing by Geographic Region – France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-32 Table 40: European 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Geographic Region – Percentage Breakdown of Unit Sales for France, Germany, Italy, UK, Spain,Russia & Rest of Europe Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-33 Table 41: European Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-34 Table 42: European Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-35 Table 43: European 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-36 4a. France III-37 Market Analysis III-37 Table 44: French Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-37 Table 45: French Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-38 Table 46: French 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-39 4b. Germany III-40 Market Analysis III-40 Table 47: German Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment –Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-40 Table 48: German Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-41 Table 49: German 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-42 4c. Italy III-43 Market Analysis III-43 Table 50: Italian Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment –Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-43 Table 51: Italian Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-44 Table 52: Italian 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-45 4d. United Kingdom III-46 A.Market Analysis III-46 Key Player III-46 Axis-Shield Plc III-46 Product Launches III-46 B.Market Analytics III-47 Table 53: UK Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment –Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-47 Table 54: UK Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-48 Table 55: UK 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-49 4e. Spain III-50 Market Analysis III-50 Table 56: Spanish Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment –Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-50 Table 57: Spanish Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-51 Table 58: Spanish 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-52 4f. Rest of Europe III-53 A.Market Analysis III-53 Key Player III-53 F. Hoffmann-La Roche Ltd III-53 Product Launch III-53 Strategic Corporate Development III-54 B.Market Analytics III-54 Table 59: Rest of Europe Market for Cholesterol & Other Cardiovascular Testing – Recent Past,Current & Future Analysis by Product Segment for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-54 Table 60: Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-55 Table 61: Rest of Europe 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-56 5. Asia-Pacific III-57 A.Market Analysis III-57 Market Outlook III-57 B.Market Analytics III-57 Table 62: Asia-Pacific Market for Cholesterol & Other Cardiovascular Testing – Recent Past, Current & Future Analysis by Product Segment for Lipid Panel Test / Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-57 Table 63: Asia-Pacific Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-58 Table 64: Asia-Pacific 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-59 6. Latin America III-60 Market Analysis III-60 Table 65: Latin American Market for Cholesterol & Other Cardiovascular Testing – Recent Past, Current & Future Analysis by Product Segment for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-60 Table 66: Latin American Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-61 Table 67: Latin American 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-62 7. Rest of World III-63 Market Analysis III-63 Table 68: Rest of World Market for Cholesterol & Other Cardiovascular Testing - Recent Past,Current & Future Analysis by Product Segment for Lipid Panel Test/Complete Lipid Profile,Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-63 Table 69: Rest of World Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment - Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-64 Table 70: Rest of World 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment - Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (include corresponding Graph/Chart) III-65 IV. COMPETITIVE LANDSCAPE

Companies Mentioned

- Abbott Diagnostics (USA) - Accutech LLC (USA) - Alfa Wassermann SpA (Italy) - Analox Instruments, Ltd (UK) - Apex Biotechnology Corporation (Taiwan) - Atherotech, Inc (USA) - Axis-Shield PLC (UK) - Bio-Rad Laboratories, Inc (USA) - Biosite, Inc (USA) - Capricorn Products, Inc (USA) - Chematics, Inc (USA) - Chemicon International, Inc (USA) - Cholestech Corporation (USA) - Cliniqa Corporation (USA) - Dade Behring, Inc (USA) - Denka Seiken Co, Ltd (Japan) - Diagnostic Chemicals Limited (Canada) - Equal Diagnostics (USA) - Exocell, Inc (USA) - Genzyme Corporation (USA) - Helena Laboratories, Inc (USA) - Hemagen Diagnostics, Inc (USA) - Home Access Health Corporation (USA) - Invitrogen Corporation (USA) - Johnson & Johnson (USA) - Kamiya Biomedical Co (USA) - Lifestream Technologies, Inc (USA) - Medical Innovations International, Inc (USA) - Nichols Institute Diagnostics (USA) - Polymer Technology Systems, Inc (USA) - Quantimetrix Corporation (USA) - Roche Diagnostics (Schweiz) AG (Switzerland) - Terumo Corporation (Japan) - The Binding Site Ltd (UK) - Wako Chemicals USA, Inc (USA)